Retrovirus vector production and transduction: Modulation by the cell cycle

Journal of General Virology

Volumn 84, Issue 11, 2003, Pages 3131-3141

  Dolnikov, Alla ^a,b,d   Wotherspoon, Simon ^b,c   Millington, Michelle ^a,b,d   Symonds, Geoff ^a,b,c,d,e  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Johnson and Johnson Research   (Australia)

^d CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

^e JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PARAMETERS; CELL CYCLE S PHASE; CELL SYNCHRONIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VIRION; VIRUS EXPRESSION;

ANIMALS; CELL CYCLE; CELL LINE; G2 PHASE; GENETIC VECTORS; HUMANS; MITOSIS; RETROVIRIDAE; TRANSDUCTION, GENETIC; VIRUS CULTIVATION; VIRUS INTEGRATION;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0242288606     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19099-0     Document Type: Article

References (31)

1. Abonour, R., Williams, D. A., Einborn, L. & 15 other authors (2000). Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med 6, 652-658.
2. Agarwal, M., Austin, T. W., Morel, F., Chen, J., Bohnlein, E. & Plavec, I. (1998). Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J Virol 72, 3720-3728.
3. Andreadis, S. T., Brott, D., Fuller, A. O. & Palsson, B. O. (1997). Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J Virol 71, 7541-7548.
4. + cells. J Gene Med 3, 219-227.
5. Dick, J. E. (2000). Gene therapy turns the corner. Nat Med 6, 624-626.
6. WAF1 expression acts to reverse myc myelomonocytic cell transformation. Cancer Gene Ther 7, 1491-1503.
7. Frisa, P. S. & Jacobberger, J. W. (2002). Cell density related gene expression: SV40 large T antigen levels in immortalized astrocyte lines. BMC Cell Biol 3, 10.
8. Goh, W. C., Rogel, M. E., Kinsey, C. M., Michael, S. F., Fultz, P. N., Nowak, M. A., Hahn, B. H. & Emerman, M. (1998). HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med 4, 65-71.
9. Hawley, R. G., Lieu, F. H., Fong, A. Z. & Hawley, T. S. (1994). Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1, 136-138.
10. Holt, S. E., Aisner, D. L., Shay, J. W. & Wright, W. E. (1997). Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci U S A 94, 10687-10692.
11. Huberman, J. A. (1981). New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual inhibitor of DNA polymerase alpha. Cell 23, 647-648.
12. Karn, J., Watson, J. V., Lowe, A. D., Green, S. M. & Vedeckis, W. (1989). Regulation of cell cycle duration by c-myc levels. Oncogene 4, 773-787.
13. Lewis, P. F. & Emerman, M. (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68, 510-516.
14. 2 arrest and gene expression by 2-aminopurine in human U937 promonocytic-macrophage cells. Exp Cell Res 219, 442-448.
15. Malech, H. L. (2000). Use of serum-free medium with fibronectin fragment enhanced transduction in a system of gas permeable plastic containers to achieve high levels of retrovirus transduction at clinical scale. Stem Cells 18, 155-156.
16. McTaggart, S. & Al-Rubeai, M. (2000). Effects of culture parameters on the production of retroviral vectors by human packaging cell line. Biotechnol Prog 16, 859-865.
17. Miller, A. D. (1992). Retroviral vectors. Curr Top Microbiol Immunol 158, 1-24.
18. Miller, D. G., Adam, M. A. & Miller, A. D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10, 4239-4242; erratum 12, 433.
19. Morgan, J. R., Ledoux, J. M., Snow, R. G., Tompkins, R. G. & Yarmush, M. L. (1995). Retrovirus infection: effect of time and target cell number. J Virol 69, 6994-7000.
20. Moritz, T., Dutt, P., Xiao, X., Carstanjen, D., Vik, T., Hanenberg, H. & Williams, D. A. (1996). Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 88, 855-862.
21. Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 90, 8392-8396.
22. Pollok, K. E., van Der Loo, J. C., Cooper, R. J. & 8 other authors (2001). Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood. Hum Gene Ther 12, 2095-2108.
23. Reeves, L., Smucker, P. & Cornetta, K. (2000). Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience. Hum Gene Ther 11, 2093-2103.
24. Roe, T., Reynolds, T. C., Yu, G. & Brown, P. O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12, 2099-2108.
25. Romano, G., Pacilio, C. & Giordano, A. (1999). Gene transfer technology in therapy: current applications and future goals. Stem Cells 17, 191-202.
26. Shounan, Y., Dolnikov, A., MacKenzie, K. L., Miller, M., Chan, Y. Y. & Symonds, G. (1996). Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. Leukemia 10, 1619-1628.
27. Sladek, T. L. & Jacobberger, J. W. (1998). Cell cycle analysis of retroviral vector gene expression during early infection. Cytometry 31, 235-241.
28. + cells. Exp Hematol 26, 53-62.
29. + cells before and after cytokine stimulation. Blood 90, 194-203.
30. + cells. Transfusion 41, 213-218.
31. Zieve, G. W., Turnbull, D., Mullins, J. M. & McIntosh, J. R. (1980). Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Nocodazole accumulated mitotic cells. Exp Cell Res 126, 397-405.